Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease-causing mutations or functional polymorphisms?

Frank Lehmann-Horn1

  • 1Department Applied Physiology, Ulm University, Germany. frank.lehmann-horn@medizin.uni-ulm.de

Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology
|December 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Paxilline Prevents the Onset of Myotonic Stiffness in Pharmacologically Induced Myotonia: A Preclinical Investigation.

Frontiers in physiology·2020
Same author

Correction to: Preclinical pharmacological in vitro investigations on low chloride conductance myotonia: effects of potassium regulation.

Pflugers Archiv : European journal of physiology·2020
Same author

Preclinical pharmacological in vitro investigations on low chloride conductance myotonia: effects of potassium regulation.

Pflugers Archiv : European journal of physiology·2020
Same author

Infantile-Onset Paroxysmal Movement Disorder and Episodic Ataxia Associated with a TBC1D24 Mutation.

Neuropediatrics·2019
Same author

Strength and muscle structure preserved during long-term therapy in a patient with hypokalemic periodic paralysis (Cav1.1-R1239G).

Journal of neurology·2019
Same author

Kir2.2 p.Thr140Met: a genetic susceptibility to sporadic periodic paralysis.

Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology·2019

Distinguishing disease-causing genetic mutations from benign polymorphisms is challenging. A new mathematical algorithm helps determine necessary healthy controls, extending criteria for mutation identification in neuromuscular diseases.

Area of Science:

  • Molecular genetics
  • Neuromuscular diseases
  • Medical genetics

Background:

  • Molecular genetics is increasingly used across medical disciplines, especially for neuromuscular diseases.
  • Geneticists may lack awareness of the limitations and potential pitfalls of genetic techniques.
  • Current criteria are insufficient for differentiating disease-causing mutations from benign polymorphisms.

Purpose of the Study:

  • To introduce a mathematical algorithm for calculating the number of healthy controls needed based on genetic alteration prevalence.
  • To extend the genetic criteria for identifying disease-causing mutations.
  • To critically evaluate the significance of functional studies versus genetic studies.

Main Methods:

  • Development of a novel mathematical algorithm.

Related Experiment Videos

  • Analysis of genetic alteration prevalence in patient cohorts.
  • Extension of established genetic criteria for mutation classification.

    • Main Results:

    • The algorithm provides a quantitative approach to determine adequate sample sizes for control groups.
    • Enhanced genetic criteria offer improved accuracy in distinguishing pathogenic mutations.
    • The study highlights the complementary role of functional studies in genetic research.

    Conclusions:

    • The developed algorithm aids researchers in designing more robust genetic studies for neuromuscular diseases.
    • Refined genetic criteria improve the reliable identification of disease-causing mutations.
    • A balanced approach integrating genetic and functional studies is crucial for advancing neuromuscular disease research.